nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoprofen—PTGS2—urinary bladder cancer	0.497	1	CbGaD
Fenoprofen—PTGS2—Cisplatin—urinary bladder cancer	0.08	0.252	CbGbCtD
Fenoprofen—PTGS2—Etoposide—urinary bladder cancer	0.0786	0.248	CbGbCtD
Fenoprofen—PTGS1—Etoposide—urinary bladder cancer	0.0664	0.209	CbGbCtD
Fenoprofen—ALB—Fluorouracil—urinary bladder cancer	0.0594	0.187	CbGbCtD
Fenoprofen—ALB—Methotrexate—urinary bladder cancer	0.0328	0.103	CbGbCtD
Fenoprofen—Suprofen—UGT2B7—urinary bladder cancer	0.00134	0.182	CrCbGaD
Fenoprofen—Naproxen—UGT2B7—urinary bladder cancer	0.00106	0.142	CrCbGaD
Fenoprofen—Flurbiprofen—UGT2B7—urinary bladder cancer	0.000756	0.102	CrCbGaD
Fenoprofen—Ibuprofen—UGT2B7—urinary bladder cancer	0.000674	0.0909	CrCbGaD
Fenoprofen—Ketoprofen—CXCL8—urinary bladder cancer	0.000387	0.0522	CrCbGaD
Fenoprofen—Ibuprofen—CXCL8—urinary bladder cancer	0.000381	0.0514	CrCbGaD
Fenoprofen—Carprofen—PTGS2—urinary bladder cancer	0.000359	0.0484	CrCbGaD
Fenoprofen—Tiaprofenic acid—PTGS2—urinary bladder cancer	0.000292	0.0395	CrCbGaD
Fenoprofen—Nepafenac—PTGS2—urinary bladder cancer	0.000278	0.0376	CrCbGaD
Fenoprofen—Fenbufen—PTGS2—urinary bladder cancer	0.000266	0.0359	CrCbGaD
Fenoprofen—Ibuprofen—PPARG—urinary bladder cancer	0.000263	0.0355	CrCbGaD
Fenoprofen—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.000249	0.00166	CcSEcCtD
Fenoprofen—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000249	0.00166	CcSEcCtD
Fenoprofen—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000246	0.00164	CcSEcCtD
Fenoprofen—Insomnia—Fluorouracil—urinary bladder cancer	0.000245	0.00164	CcSEcCtD
Fenoprofen—Somnolence—Gemcitabine—urinary bladder cancer	0.000245	0.00164	CcSEcCtD
Fenoprofen—Anorexia—Cisplatin—urinary bladder cancer	0.000245	0.00164	CcSEcCtD
Fenoprofen—Pancreatitis—Methotrexate—urinary bladder cancer	0.000243	0.00163	CcSEcCtD
Fenoprofen—Discomfort—Etoposide—urinary bladder cancer	0.000243	0.00162	CcSEcCtD
Fenoprofen—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000242	0.00162	CcSEcCtD
Fenoprofen—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000242	0.00162	CcSEcCtD
Fenoprofen—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000242	0.00161	CcSEcCtD
Fenoprofen—Somnolence—Fluorouracil—urinary bladder cancer	0.000241	0.00161	CcSEcCtD
Fenoprofen—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.00024	0.00161	CcSEcCtD
Fenoprofen—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00024	0.0016	CcSEcCtD
Fenoprofen—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000239	0.0016	CcSEcCtD
Fenoprofen—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000238	0.00159	CcSEcCtD
Fenoprofen—Fatigue—Gemcitabine—urinary bladder cancer	0.000238	0.00159	CcSEcCtD
Fenoprofen—Gastritis—Epirubicin—urinary bladder cancer	0.000238	0.00159	CcSEcCtD
Fenoprofen—Confusional state—Etoposide—urinary bladder cancer	0.000237	0.00159	CcSEcCtD
Fenoprofen—Constipation—Gemcitabine—urinary bladder cancer	0.000236	0.00158	CcSEcCtD
Fenoprofen—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000236	0.00158	CcSEcCtD
Fenoprofen—Pancytopenia—Methotrexate—urinary bladder cancer	0.000236	0.00157	CcSEcCtD
Fenoprofen—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000236	0.00157	CcSEcCtD
Fenoprofen—Asthenia—Thiotepa—urinary bladder cancer	0.000235	0.00157	CcSEcCtD
Fenoprofen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—urinary bladder cancer	0.000234	0.0081	CbGpPWpGaD
Fenoprofen—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000234	0.00156	CcSEcCtD
Fenoprofen—Dysuria—Methotrexate—urinary bladder cancer	0.000232	0.00155	CcSEcCtD
Fenoprofen—Pruritus—Thiotepa—urinary bladder cancer	0.000232	0.00155	CcSEcCtD
Fenoprofen—PTGS2—C-MYB transcription factor network—MPO—urinary bladder cancer	0.000231	0.008	CbGpPWpGaD
Fenoprofen—Salsalate—PTGS2—urinary bladder cancer	0.000231	0.0312	CrCbGaD
Fenoprofen—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000231	0.00154	CcSEcCtD
Fenoprofen—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.000231	0.00154	CcSEcCtD
Fenoprofen—Tachycardia—Etoposide—urinary bladder cancer	0.00023	0.00154	CcSEcCtD
Fenoprofen—Dyspnoea—Cisplatin—urinary bladder cancer	0.000229	0.00153	CcSEcCtD
Fenoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—urinary bladder cancer	0.000229	0.00792	CbGpPWpGaD
Fenoprofen—PTGS1—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000228	0.00788	CbGpPWpGaD
Fenoprofen—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000228	0.00152	CcSEcCtD
Fenoprofen—Pancreatitis—Epirubicin—urinary bladder cancer	0.000228	0.00152	CcSEcCtD
Fenoprofen—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000227	0.00152	CcSEcCtD
Fenoprofen—ALB—Folate Metabolism—MPO—urinary bladder cancer	0.000227	0.00785	CbGpPWpGaD
Fenoprofen—Anorexia—Etoposide—urinary bladder cancer	0.000224	0.0015	CcSEcCtD
Fenoprofen—Diarrhoea—Thiotepa—urinary bladder cancer	0.000224	0.0015	CcSEcCtD
Fenoprofen—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000224	0.0015	CcSEcCtD
Fenoprofen—Decreased appetite—Cisplatin—urinary bladder cancer	0.000223	0.00149	CcSEcCtD
Fenoprofen—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000223	0.00149	CcSEcCtD
Fenoprofen—PTGS2—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000223	0.0077	CbGpPWpGaD
Fenoprofen—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000222	0.00149	CcSEcCtD
Fenoprofen—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000222	0.00148	CcSEcCtD
Fenoprofen—Suprofen—PTGS2—urinary bladder cancer	0.000222	0.0299	CrCbGaD
Fenoprofen—Depression—Methotrexate—urinary bladder cancer	0.000221	0.00147	CcSEcCtD
Fenoprofen—Pancytopenia—Epirubicin—urinary bladder cancer	0.00022	0.00147	CcSEcCtD
Fenoprofen—Gastritis—Doxorubicin—urinary bladder cancer	0.00022	0.00147	CcSEcCtD
Fenoprofen—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000219	0.00147	CcSEcCtD
Fenoprofen—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000218	0.00146	CcSEcCtD
Fenoprofen—Renal failure—Methotrexate—urinary bladder cancer	0.000217	0.00145	CcSEcCtD
Fenoprofen—Dysuria—Epirubicin—urinary bladder cancer	0.000217	0.00145	CcSEcCtD
Fenoprofen—Dizziness—Thiotepa—urinary bladder cancer	0.000217	0.00145	CcSEcCtD
Fenoprofen—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000216	0.00144	CcSEcCtD
Fenoprofen—Urticaria—Fluorouracil—urinary bladder cancer	0.000215	0.00144	CcSEcCtD
Fenoprofen—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000214	0.00143	CcSEcCtD
Fenoprofen—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000212	0.00142	CcSEcCtD
Fenoprofen—Haematuria—Methotrexate—urinary bladder cancer	0.000211	0.00141	CcSEcCtD
Fenoprofen—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000211	0.00141	CcSEcCtD
Fenoprofen—Dyspnoea—Etoposide—urinary bladder cancer	0.00021	0.0014	CcSEcCtD
Fenoprofen—PTGS2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.00021	0.00725	CbGpPWpGaD
Fenoprofen—Somnolence—Etoposide—urinary bladder cancer	0.000209	0.0014	CcSEcCtD
Fenoprofen—Vomiting—Thiotepa—urinary bladder cancer	0.000208	0.00139	CcSEcCtD
Fenoprofen—PTGS1—Biological oxidations—NAT2—urinary bladder cancer	0.000208	0.00719	CbGpPWpGaD
Fenoprofen—Rash—Thiotepa—urinary bladder cancer	0.000207	0.00138	CcSEcCtD
Fenoprofen—Dermatitis—Thiotepa—urinary bladder cancer	0.000207	0.00138	CcSEcCtD
Fenoprofen—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000206	0.00138	CcSEcCtD
Fenoprofen—Headache—Thiotepa—urinary bladder cancer	0.000205	0.00137	CcSEcCtD
Fenoprofen—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000205	0.00137	CcSEcCtD
Fenoprofen—Decreased appetite—Etoposide—urinary bladder cancer	0.000205	0.00137	CcSEcCtD
Fenoprofen—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000204	0.00136	CcSEcCtD
Fenoprofen—Renal failure—Epirubicin—urinary bladder cancer	0.000203	0.00136	CcSEcCtD
Fenoprofen—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000203	0.00136	CcSEcCtD
Fenoprofen—Body temperature increased—Cisplatin—urinary bladder cancer	0.000203	0.00136	CcSEcCtD
Fenoprofen—Fatigue—Etoposide—urinary bladder cancer	0.000203	0.00136	CcSEcCtD
Fenoprofen—Jaundice—Epirubicin—urinary bladder cancer	0.000202	0.00135	CcSEcCtD
Fenoprofen—Bumetanide—PTGS2—urinary bladder cancer	0.000202	0.0272	CrCbGaD
Fenoprofen—Constipation—Etoposide—urinary bladder cancer	0.000201	0.00135	CcSEcCtD
Fenoprofen—Dysuria—Doxorubicin—urinary bladder cancer	0.000201	0.00134	CcSEcCtD
Fenoprofen—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.0002	0.00134	CcSEcCtD
Fenoprofen—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.0002	0.00133	CcSEcCtD
Fenoprofen—Haemoglobin—Methotrexate—urinary bladder cancer	0.0002	0.00133	CcSEcCtD
Fenoprofen—Haemorrhage—Methotrexate—urinary bladder cancer	0.000199	0.00133	CcSEcCtD
Fenoprofen—Asthenia—Gemcitabine—urinary bladder cancer	0.000198	0.00132	CcSEcCtD
Fenoprofen—Haematuria—Epirubicin—urinary bladder cancer	0.000197	0.00132	CcSEcCtD
Fenoprofen—Pruritus—Gemcitabine—urinary bladder cancer	0.000195	0.0013	CcSEcCtD
Fenoprofen—Nausea—Thiotepa—urinary bladder cancer	0.000195	0.0013	CcSEcCtD
Fenoprofen—Feeling abnormal—Etoposide—urinary bladder cancer	0.000194	0.0013	CcSEcCtD
Fenoprofen—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000193	0.00129	CcSEcCtD
Fenoprofen—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000193	0.00129	CcSEcCtD
Fenoprofen—Pruritus—Fluorouracil—urinary bladder cancer	0.000192	0.00128	CcSEcCtD
Fenoprofen—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.00019	0.00127	CcSEcCtD
Fenoprofen—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000189	0.00127	CcSEcCtD
Fenoprofen—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000189	0.00126	CcSEcCtD
Fenoprofen—Renal failure—Doxorubicin—urinary bladder cancer	0.000188	0.00126	CcSEcCtD
Fenoprofen—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000188	0.00125	CcSEcCtD
Fenoprofen—Urticaria—Etoposide—urinary bladder cancer	0.000187	0.00125	CcSEcCtD
Fenoprofen—Haemoglobin—Epirubicin—urinary bladder cancer	0.000187	0.00125	CcSEcCtD
Fenoprofen—Jaundice—Doxorubicin—urinary bladder cancer	0.000187	0.00125	CcSEcCtD
Fenoprofen—Abdominal pain—Etoposide—urinary bladder cancer	0.000186	0.00124	CcSEcCtD
Fenoprofen—Body temperature increased—Etoposide—urinary bladder cancer	0.000186	0.00124	CcSEcCtD
Fenoprofen—Haemorrhage—Epirubicin—urinary bladder cancer	0.000186	0.00124	CcSEcCtD
Fenoprofen—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000186	0.00124	CcSEcCtD
Fenoprofen—Tinnitus—Methotrexate—urinary bladder cancer	0.000185	0.00124	CcSEcCtD
Fenoprofen—Asthenia—Cisplatin—urinary bladder cancer	0.000184	0.00123	CcSEcCtD
Fenoprofen—PTGS2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000184	0.00636	CbGpPWpGaD
Fenoprofen—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000183	0.00122	CcSEcCtD
Fenoprofen—Haematuria—Doxorubicin—urinary bladder cancer	0.000183	0.00122	CcSEcCtD
Fenoprofen—PTGS2—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000181	0.00625	CbGpPWpGaD
Fenoprofen—ALB—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.00018	0.00623	CbGpPWpGaD
Fenoprofen—Dizziness—Fluorouracil—urinary bladder cancer	0.000179	0.0012	CcSEcCtD
Fenoprofen—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000179	0.00119	CcSEcCtD
Fenoprofen—Mefenamic acid—PTGS2—urinary bladder cancer	0.000177	0.0239	CrCbGaD
Fenoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—urinary bladder cancer	0.000177	0.00612	CbGpPWpGaD
Fenoprofen—PTGS1—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000176	0.00609	CbGpPWpGaD
Fenoprofen—Diarrhoea—Cisplatin—urinary bladder cancer	0.000176	0.00118	CcSEcCtD
Fenoprofen—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000176	0.00117	CcSEcCtD
Fenoprofen—Alopecia—Methotrexate—urinary bladder cancer	0.000175	0.00117	CcSEcCtD
Fenoprofen—Vomiting—Gemcitabine—urinary bladder cancer	0.000175	0.00117	CcSEcCtD
Fenoprofen—ALB—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000175	0.00606	CbGpPWpGaD
Fenoprofen—ALB—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	0.000175	0.00606	CbGpPWpGaD
Fenoprofen—Naproxen—PTGS2—urinary bladder cancer	0.000174	0.0235	CrCbGaD
Fenoprofen—Rash—Gemcitabine—urinary bladder cancer	0.000174	0.00116	CcSEcCtD
Fenoprofen—Dermatitis—Gemcitabine—urinary bladder cancer	0.000174	0.00116	CcSEcCtD
Fenoprofen—Hypersensitivity—Etoposide—urinary bladder cancer	0.000174	0.00116	CcSEcCtD
Fenoprofen—Tinnitus—Epirubicin—urinary bladder cancer	0.000173	0.00116	CcSEcCtD
Fenoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—urinary bladder cancer	0.000173	0.00598	CbGpPWpGaD
Fenoprofen—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000173	0.00115	CcSEcCtD
Fenoprofen—Headache—Gemcitabine—urinary bladder cancer	0.000173	0.00115	CcSEcCtD
Fenoprofen—Vomiting—Fluorouracil—urinary bladder cancer	0.000172	0.00115	CcSEcCtD
Fenoprofen—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000172	0.00115	CcSEcCtD
Fenoprofen—Rash—Fluorouracil—urinary bladder cancer	0.000171	0.00114	CcSEcCtD
Fenoprofen—Dermatitis—Fluorouracil—urinary bladder cancer	0.000171	0.00114	CcSEcCtD
Fenoprofen—Headache—Fluorouracil—urinary bladder cancer	0.00017	0.00114	CcSEcCtD
Fenoprofen—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000169	0.00113	CcSEcCtD
Fenoprofen—Dysgeusia—Methotrexate—urinary bladder cancer	0.000169	0.00113	CcSEcCtD
Fenoprofen—Asthenia—Etoposide—urinary bladder cancer	0.000169	0.00113	CcSEcCtD
Fenoprofen—PTGS1—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000168	0.00581	CbGpPWpGaD
Fenoprofen—Pruritus—Etoposide—urinary bladder cancer	0.000167	0.00111	CcSEcCtD
Fenoprofen—PTGS1—Biological oxidations—HPGDS—urinary bladder cancer	0.000166	0.00575	CbGpPWpGaD
Fenoprofen—Alopecia—Epirubicin—urinary bladder cancer	0.000164	0.0011	CcSEcCtD
Fenoprofen—Nausea—Gemcitabine—urinary bladder cancer	0.000164	0.00109	CcSEcCtD
Fenoprofen—Vomiting—Cisplatin—urinary bladder cancer	0.000163	0.00109	CcSEcCtD
Fenoprofen—Vision blurred—Methotrexate—urinary bladder cancer	0.000163	0.00109	CcSEcCtD
Fenoprofen—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000163	0.00109	CcSEcCtD
Fenoprofen—Rash—Cisplatin—urinary bladder cancer	0.000162	0.00108	CcSEcCtD
Fenoprofen—Dermatitis—Cisplatin—urinary bladder cancer	0.000162	0.00108	CcSEcCtD
Fenoprofen—PTGS1—Biological oxidations—GSTT1—urinary bladder cancer	0.000161	0.00558	CbGpPWpGaD
Fenoprofen—Diarrhoea—Etoposide—urinary bladder cancer	0.000161	0.00108	CcSEcCtD
Fenoprofen—Nausea—Fluorouracil—urinary bladder cancer	0.000161	0.00108	CcSEcCtD
Fenoprofen—PTGS2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000161	0.00555	CbGpPWpGaD
Fenoprofen—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00016	0.00107	CcSEcCtD
Fenoprofen—Tinnitus—Doxorubicin—urinary bladder cancer	0.00016	0.00107	CcSEcCtD
Fenoprofen—Flatulence—Epirubicin—urinary bladder cancer	0.000159	0.00107	CcSEcCtD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000159	0.0055	CbGpPWpGaD
Fenoprofen—Tension—Epirubicin—urinary bladder cancer	0.000159	0.00106	CcSEcCtD
Fenoprofen—Dysgeusia—Epirubicin—urinary bladder cancer	0.000158	0.00106	CcSEcCtD
Fenoprofen—Nervousness—Epirubicin—urinary bladder cancer	0.000157	0.00105	CcSEcCtD
Fenoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—urinary bladder cancer	0.000157	0.00543	CbGpPWpGaD
Fenoprofen—Malaise—Methotrexate—urinary bladder cancer	0.000156	0.00104	CcSEcCtD
Fenoprofen—Dizziness—Etoposide—urinary bladder cancer	0.000156	0.00104	CcSEcCtD
Fenoprofen—PTGS1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000156	0.00538	CbGpPWpGaD
Fenoprofen—PTGS1—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000155	0.00537	CbGpPWpGaD
Fenoprofen—ALB—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	0.000154	0.00533	CbGpPWpGaD
Fenoprofen—Nausea—Cisplatin—urinary bladder cancer	0.000153	0.00102	CcSEcCtD
Fenoprofen—Vision blurred—Epirubicin—urinary bladder cancer	0.000152	0.00102	CcSEcCtD
Fenoprofen—Alopecia—Doxorubicin—urinary bladder cancer	0.000152	0.00102	CcSEcCtD
Fenoprofen—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00015	0.001	CcSEcCtD
Fenoprofen—Convulsion—Methotrexate—urinary bladder cancer	0.00015	0.001	CcSEcCtD
Fenoprofen—Vomiting—Etoposide—urinary bladder cancer	0.00015	0.001	CcSEcCtD
Fenoprofen—Rash—Etoposide—urinary bladder cancer	0.000148	0.000992	CcSEcCtD
Fenoprofen—Dermatitis—Etoposide—urinary bladder cancer	0.000148	0.000991	CcSEcCtD
Fenoprofen—Headache—Etoposide—urinary bladder cancer	0.000148	0.000986	CcSEcCtD
Fenoprofen—Flatulence—Doxorubicin—urinary bladder cancer	0.000147	0.000986	CcSEcCtD
Fenoprofen—Tension—Doxorubicin—urinary bladder cancer	0.000147	0.000981	CcSEcCtD
Fenoprofen—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000147	0.000979	CcSEcCtD
Fenoprofen—Malaise—Epirubicin—urinary bladder cancer	0.000146	0.000975	CcSEcCtD
Fenoprofen—Discomfort—Methotrexate—urinary bladder cancer	0.000145	0.000972	CcSEcCtD
Fenoprofen—Nervousness—Doxorubicin—urinary bladder cancer	0.000145	0.000971	CcSEcCtD
Fenoprofen—PTGS2—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.000145	0.005	CbGpPWpGaD
Fenoprofen—PTGS2—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.000145	0.005	CbGpPWpGaD
Fenoprofen—Palpitations—Epirubicin—urinary bladder cancer	0.000143	0.000955	CcSEcCtD
Fenoprofen—ALB—Folate Metabolism—SOD2—urinary bladder cancer	0.000143	0.00493	CbGpPWpGaD
Fenoprofen—Confusional state—Methotrexate—urinary bladder cancer	0.000142	0.000951	CcSEcCtD
Fenoprofen—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000141	0.000943	CcSEcCtD
Fenoprofen—Vision blurred—Doxorubicin—urinary bladder cancer	0.000141	0.000943	CcSEcCtD
Fenoprofen—Convulsion—Epirubicin—urinary bladder cancer	0.00014	0.000937	CcSEcCtD
Fenoprofen—PTGS2—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.00014	0.00484	CbGpPWpGaD
Fenoprofen—Nausea—Etoposide—urinary bladder cancer	0.00014	0.000935	CcSEcCtD
Fenoprofen—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000139	0.000928	CcSEcCtD
Fenoprofen—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000138	0.000923	CcSEcCtD
Fenoprofen—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000136	0.000911	CcSEcCtD
Fenoprofen—Discomfort—Epirubicin—urinary bladder cancer	0.000136	0.000909	CcSEcCtD
Fenoprofen—ALB—Folate Metabolism—GPX1—urinary bladder cancer	0.000136	0.0047	CbGpPWpGaD
Fenoprofen—Malaise—Doxorubicin—urinary bladder cancer	0.000135	0.000902	CcSEcCtD
Fenoprofen—Dry mouth—Epirubicin—urinary bladder cancer	0.000135	0.0009	CcSEcCtD
Fenoprofen—Anorexia—Methotrexate—urinary bladder cancer	0.000134	0.000899	CcSEcCtD
Fenoprofen—PTGS2—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000133	0.00462	CbGpPWpGaD
Fenoprofen—Confusional state—Epirubicin—urinary bladder cancer	0.000133	0.00089	CcSEcCtD
Fenoprofen—Palpitations—Doxorubicin—urinary bladder cancer	0.000132	0.000884	CcSEcCtD
Fenoprofen—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000132	0.000882	CcSEcCtD
Fenoprofen—Convulsion—Doxorubicin—urinary bladder cancer	0.00013	0.000867	CcSEcCtD
Fenoprofen—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000129	0.000864	CcSEcCtD
Fenoprofen—Tachycardia—Epirubicin—urinary bladder cancer	0.000129	0.000861	CcSEcCtD
Fenoprofen—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000128	0.000853	CcSEcCtD
Fenoprofen—Insomnia—Methotrexate—urinary bladder cancer	0.000128	0.000853	CcSEcCtD
Fenoprofen—Discomfort—Doxorubicin—urinary bladder cancer	0.000126	0.000841	CcSEcCtD
Fenoprofen—Anorexia—Epirubicin—urinary bladder cancer	0.000126	0.000841	CcSEcCtD
Fenoprofen—Dyspnoea—Methotrexate—urinary bladder cancer	0.000126	0.00084	CcSEcCtD
Fenoprofen—ALB—Folate Metabolism—MTHFR—urinary bladder cancer	0.000125	0.00434	CbGpPWpGaD
Fenoprofen—Somnolence—Methotrexate—urinary bladder cancer	0.000125	0.000838	CcSEcCtD
Fenoprofen—Flurbiprofen—PTGS2—urinary bladder cancer	0.000125	0.0168	CrCbGaD
Fenoprofen—Dry mouth—Doxorubicin—urinary bladder cancer	0.000125	0.000833	CcSEcCtD
Fenoprofen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	0.000124	0.0043	CbGpPWpGaD
Fenoprofen—Dyspepsia—Methotrexate—urinary bladder cancer	0.000124	0.00083	CcSEcCtD
Fenoprofen—PTGS2—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000123	0.00426	CbGpPWpGaD
Fenoprofen—Confusional state—Doxorubicin—urinary bladder cancer	0.000123	0.000823	CcSEcCtD
Fenoprofen—Decreased appetite—Methotrexate—urinary bladder cancer	0.000123	0.000819	CcSEcCtD
Fenoprofen—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000122	0.000816	CcSEcCtD
Fenoprofen—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000122	0.000814	CcSEcCtD
Fenoprofen—Fatigue—Methotrexate—urinary bladder cancer	0.000122	0.000813	CcSEcCtD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000121	0.0042	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000121	0.00417	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00012	0.00415	CbGpPWpGaD
Fenoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—urinary bladder cancer	0.00012	0.00414	CbGpPWpGaD
Fenoprofen—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00012	0.000799	CcSEcCtD
Fenoprofen—Insomnia—Epirubicin—urinary bladder cancer	0.000119	0.000798	CcSEcCtD
Fenoprofen—Tachycardia—Doxorubicin—urinary bladder cancer	0.000119	0.000797	CcSEcCtD
Fenoprofen—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000118	0.000789	CcSEcCtD
Fenoprofen—Dyspnoea—Epirubicin—urinary bladder cancer	0.000118	0.000787	CcSEcCtD
Fenoprofen—Somnolence—Epirubicin—urinary bladder cancer	0.000117	0.000784	CcSEcCtD
Fenoprofen—Anorexia—Doxorubicin—urinary bladder cancer	0.000116	0.000778	CcSEcCtD
Fenoprofen—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000116	0.000777	CcSEcCtD
Fenoprofen—Dyspepsia—Epirubicin—urinary bladder cancer	0.000116	0.000777	CcSEcCtD
Fenoprofen—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000115	0.00399	CbGpPWpGaD
Fenoprofen—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000115	0.000771	CcSEcCtD
Fenoprofen—Decreased appetite—Epirubicin—urinary bladder cancer	0.000115	0.000767	CcSEcCtD
Fenoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—urinary bladder cancer	0.000114	0.00396	CbGpPWpGaD
Fenoprofen—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000114	0.000762	CcSEcCtD
Fenoprofen—Fatigue—Epirubicin—urinary bladder cancer	0.000114	0.000761	CcSEcCtD
Fenoprofen—ALB—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000113	0.00391	CbGpPWpGaD
Fenoprofen—Constipation—Epirubicin—urinary bladder cancer	0.000113	0.000754	CcSEcCtD
Fenoprofen—Ketoprofen—PTGS2—urinary bladder cancer	0.000113	0.0152	CrCbGaD
Fenoprofen—Urticaria—Methotrexate—urinary bladder cancer	0.000112	0.000749	CcSEcCtD
Fenoprofen—PTGS1—Biological oxidations—GSTP1—urinary bladder cancer	0.000112	0.00387	CbGpPWpGaD
Fenoprofen—Abdominal pain—Methotrexate—urinary bladder cancer	0.000112	0.000745	CcSEcCtD
Fenoprofen—Body temperature increased—Methotrexate—urinary bladder cancer	0.000112	0.000745	CcSEcCtD
Fenoprofen—Ibuprofen—PTGS2—urinary bladder cancer	0.000111	0.015	CrCbGaD
Fenoprofen—Insomnia—Doxorubicin—urinary bladder cancer	0.00011	0.000738	CcSEcCtD
Fenoprofen—PTGS2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.00011	0.0038	CbGpPWpGaD
Fenoprofen—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000109	0.000728	CcSEcCtD
Fenoprofen—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000109	0.000727	CcSEcCtD
Fenoprofen—Somnolence—Doxorubicin—urinary bladder cancer	0.000109	0.000726	CcSEcCtD
Fenoprofen—ALB—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000108	0.00373	CbGpPWpGaD
Fenoprofen—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000108	0.000721	CcSEcCtD
Fenoprofen—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000108	0.000719	CcSEcCtD
Fenoprofen—PTGS2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000107	0.00369	CbGpPWpGaD
Fenoprofen—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000106	0.00071	CcSEcCtD
Fenoprofen—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000105	0.000705	CcSEcCtD
Fenoprofen—Fatigue—Doxorubicin—urinary bladder cancer	0.000105	0.000704	CcSEcCtD
Fenoprofen—Urticaria—Epirubicin—urinary bladder cancer	0.000105	0.000701	CcSEcCtD
Fenoprofen—Constipation—Doxorubicin—urinary bladder cancer	0.000104	0.000698	CcSEcCtD
Fenoprofen—Body temperature increased—Epirubicin—urinary bladder cancer	0.000104	0.000697	CcSEcCtD
Fenoprofen—Abdominal pain—Epirubicin—urinary bladder cancer	0.000104	0.000697	CcSEcCtD
Fenoprofen—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000104	0.000695	CcSEcCtD
Fenoprofen—PTGS1—Biological oxidations—GSTM1—urinary bladder cancer	0.000103	0.00355	CbGpPWpGaD
Fenoprofen—Asthenia—Methotrexate—urinary bladder cancer	0.000101	0.000676	CcSEcCtD
Fenoprofen—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000101	0.000673	CcSEcCtD
Fenoprofen—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	9.99e-05	0.000667	CcSEcCtD
Fenoprofen—Pruritus—Methotrexate—urinary bladder cancer	9.98e-05	0.000667	CcSEcCtD
Fenoprofen—ALB—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	9.97e-05	0.00345	CbGpPWpGaD
Fenoprofen—PTGS2—C-MYB transcription factor network—CREBBP—urinary bladder cancer	9.96e-05	0.00344	CbGpPWpGaD
Fenoprofen—PTGS1—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	9.9e-05	0.00342	CbGpPWpGaD
Fenoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	9.78e-05	0.00338	CbGpPWpGaD
Fenoprofen—Hypersensitivity—Epirubicin—urinary bladder cancer	9.73e-05	0.00065	CcSEcCtD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	9.71e-05	0.00336	CbGpPWpGaD
Fenoprofen—Urticaria—Doxorubicin—urinary bladder cancer	9.7e-05	0.000648	CcSEcCtD
Fenoprofen—Body temperature increased—Doxorubicin—urinary bladder cancer	9.66e-05	0.000645	CcSEcCtD
Fenoprofen—Abdominal pain—Doxorubicin—urinary bladder cancer	9.66e-05	0.000645	CcSEcCtD
Fenoprofen—Diarrhoea—Methotrexate—urinary bladder cancer	9.65e-05	0.000645	CcSEcCtD
Fenoprofen—PTGS2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	9.57e-05	0.00331	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	9.53e-05	0.00329	CbGpPWpGaD
Fenoprofen—Asthenia—Epirubicin—urinary bladder cancer	9.47e-05	0.000633	CcSEcCtD
Fenoprofen—PTGS2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	9.36e-05	0.00324	CbGpPWpGaD
Fenoprofen—Pruritus—Epirubicin—urinary bladder cancer	9.34e-05	0.000624	CcSEcCtD
Fenoprofen—Dizziness—Methotrexate—urinary bladder cancer	9.33e-05	0.000623	CcSEcCtD
Fenoprofen—Diarrhoea—Epirubicin—urinary bladder cancer	9.03e-05	0.000604	CcSEcCtD
Fenoprofen—Hypersensitivity—Doxorubicin—urinary bladder cancer	9e-05	0.000601	CcSEcCtD
Fenoprofen—Vomiting—Methotrexate—urinary bladder cancer	8.97e-05	0.000599	CcSEcCtD
Fenoprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	8.91e-05	0.00308	CbGpPWpGaD
Fenoprofen—ALB—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	8.9e-05	0.00308	CbGpPWpGaD
Fenoprofen—Rash—Methotrexate—urinary bladder cancer	8.89e-05	0.000594	CcSEcCtD
Fenoprofen—Dermatitis—Methotrexate—urinary bladder cancer	8.89e-05	0.000594	CcSEcCtD
Fenoprofen—PTGS2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	8.84e-05	0.00306	CbGpPWpGaD
Fenoprofen—Headache—Methotrexate—urinary bladder cancer	8.84e-05	0.000591	CcSEcCtD
Fenoprofen—Asthenia—Doxorubicin—urinary bladder cancer	8.76e-05	0.000586	CcSEcCtD
Fenoprofen—Dizziness—Epirubicin—urinary bladder cancer	8.73e-05	0.000583	CcSEcCtD
Fenoprofen—PTGS2—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	8.72e-05	0.00302	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—CDK4—urinary bladder cancer	8.7e-05	0.00301	CbGpPWpGaD
Fenoprofen—Pruritus—Doxorubicin—urinary bladder cancer	8.64e-05	0.000578	CcSEcCtD
Fenoprofen—Vomiting—Epirubicin—urinary bladder cancer	8.39e-05	0.000561	CcSEcCtD
Fenoprofen—Nausea—Methotrexate—urinary bladder cancer	8.38e-05	0.00056	CcSEcCtD
Fenoprofen—Diarrhoea—Doxorubicin—urinary bladder cancer	8.36e-05	0.000559	CcSEcCtD
Fenoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	8.34e-05	0.00288	CbGpPWpGaD
Fenoprofen—Rash—Epirubicin—urinary bladder cancer	8.32e-05	0.000556	CcSEcCtD
Fenoprofen—Dermatitis—Epirubicin—urinary bladder cancer	8.32e-05	0.000556	CcSEcCtD
Fenoprofen—ALB—Platelet degranulation—IGF1—urinary bladder cancer	8.28e-05	0.00286	CbGpPWpGaD
Fenoprofen—Headache—Epirubicin—urinary bladder cancer	8.27e-05	0.000553	CcSEcCtD
Fenoprofen—Dizziness—Doxorubicin—urinary bladder cancer	8.08e-05	0.00054	CcSEcCtD
Fenoprofen—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	7.88e-05	0.00273	CbGpPWpGaD
Fenoprofen—Nausea—Epirubicin—urinary bladder cancer	7.84e-05	0.000524	CcSEcCtD
Fenoprofen—Vomiting—Doxorubicin—urinary bladder cancer	7.77e-05	0.000519	CcSEcCtD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	7.72e-05	0.00267	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	7.71e-05	0.00267	CbGpPWpGaD
Fenoprofen—Rash—Doxorubicin—urinary bladder cancer	7.7e-05	0.000515	CcSEcCtD
Fenoprofen—Dermatitis—Doxorubicin—urinary bladder cancer	7.69e-05	0.000514	CcSEcCtD
Fenoprofen—Headache—Doxorubicin—urinary bladder cancer	7.65e-05	0.000511	CcSEcCtD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	7.59e-05	0.00262	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—RB1—urinary bladder cancer	7.56e-05	0.00261	CbGpPWpGaD
Fenoprofen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	7.52e-05	0.0026	CbGpPWpGaD
Fenoprofen—ALB—Folate Metabolism—IL2—urinary bladder cancer	7.42e-05	0.00256	CbGpPWpGaD
Fenoprofen—PTGS2—C-MYB transcription factor network—CCND1—urinary bladder cancer	7.37e-05	0.00255	CbGpPWpGaD
Fenoprofen—Nausea—Doxorubicin—urinary bladder cancer	7.26e-05	0.000485	CcSEcCtD
Fenoprofen—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	7.13e-05	0.00247	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	6.87e-05	0.00237	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	6.85e-05	0.00237	CbGpPWpGaD
Fenoprofen—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	6.78e-05	0.00235	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	6.72e-05	0.00232	CbGpPWpGaD
Fenoprofen—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	6.68e-05	0.00231	CbGpPWpGaD
Fenoprofen—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	6.64e-05	0.0023	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—GSTO2—urinary bladder cancer	6.49e-05	0.00224	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—NAT1—urinary bladder cancer	6.49e-05	0.00224	CbGpPWpGaD
Fenoprofen—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	6.44e-05	0.00223	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.39e-05	0.00221	CbGpPWpGaD
Fenoprofen—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	6.36e-05	0.0022	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—GSTO2—urinary bladder cancer	6.15e-05	0.00213	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	6.03e-05	0.00208	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	5.94e-05	0.00205	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	5.94e-05	0.00205	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	5.92e-05	0.00205	CbGpPWpGaD
Fenoprofen—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	5.91e-05	0.00204	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	5.89e-05	0.00204	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	5.76e-05	0.00199	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	5.62e-05	0.00194	CbGpPWpGaD
Fenoprofen—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	5.46e-05	0.00189	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	5.45e-05	0.00188	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	5.44e-05	0.00188	CbGpPWpGaD
Fenoprofen—ALB—Folate Metabolism—TNF—urinary bladder cancer	5.4e-05	0.00187	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	5.35e-05	0.00185	CbGpPWpGaD
Fenoprofen—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	5.31e-05	0.00183	CbGpPWpGaD
Fenoprofen—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	5.25e-05	0.00181	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.16e-05	0.00179	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—GSTO2—urinary bladder cancer	5.15e-05	0.00178	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—NAT1—urinary bladder cancer	5.15e-05	0.00178	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	5.1e-05	0.00176	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.07e-05	0.00175	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	5.05e-05	0.00175	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—PRSS3—urinary bladder cancer	4.92e-05	0.0017	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—SLC19A1—urinary bladder cancer	4.79e-05	0.00165	CbGpPWpGaD
Fenoprofen—ALB—Folate Metabolism—TP53—urinary bladder cancer	4.76e-05	0.00165	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	4.71e-05	0.00163	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—PRSS3—urinary bladder cancer	4.66e-05	0.00161	CbGpPWpGaD
Fenoprofen—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	4.64e-05	0.00161	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	4.5e-05	0.00156	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—HDAC4—urinary bladder cancer	4.45e-05	0.00154	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	4.41e-05	0.00152	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—GSTZ1—urinary bladder cancer	4.4e-05	0.00152	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.32e-05	0.00149	CbGpPWpGaD
Fenoprofen—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	4.29e-05	0.00148	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	4.24e-05	0.00147	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	4.2e-05	0.00145	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—GSTO2—urinary bladder cancer	4.17e-05	0.00144	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—NAT1—urinary bladder cancer	4.17e-05	0.00144	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.1e-05	0.00142	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	4.01e-05	0.00139	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.94e-05	0.00136	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—TYMP—urinary bladder cancer	3.93e-05	0.00136	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—PRSS3—urinary bladder cancer	3.91e-05	0.00135	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.82e-05	0.00132	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—UGT2B7—urinary bladder cancer	3.81e-05	0.00132	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.78e-05	0.00131	CbGpPWpGaD
Fenoprofen—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	3.7e-05	0.00128	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.7e-05	0.00128	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.69e-05	0.00127	CbGpPWpGaD
Fenoprofen—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	3.67e-05	0.00127	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—NAT2—urinary bladder cancer	3.56e-05	0.00123	CbGpPWpGaD
Fenoprofen—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.54e-05	0.00123	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—LIG1—urinary bladder cancer	3.53e-05	0.00122	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.52e-05	0.00122	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—CYP4B1—urinary bladder cancer	3.43e-05	0.00119	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.42e-05	0.00118	CbGpPWpGaD
Fenoprofen—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	3.36e-05	0.00116	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—IFNA2—urinary bladder cancer	3.27e-05	0.00113	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—SLC19A1—urinary bladder cancer	3.24e-05	0.00112	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—PRSS3—urinary bladder cancer	3.16e-05	0.00109	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.13e-05	0.00108	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—TYMP—urinary bladder cancer	3.12e-05	0.00108	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—RRM2—urinary bladder cancer	3.07e-05	0.00106	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.06e-05	0.00106	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3e-05	0.00104	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3e-05	0.00104	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.85e-05	0.000987	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—HPGDS—urinary bladder cancer	2.84e-05	0.000983	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—ENO2—urinary bladder cancer	2.84e-05	0.000983	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.83e-05	0.000979	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.83e-05	0.000977	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—NAT2—urinary bladder cancer	2.82e-05	0.000976	CbGpPWpGaD
Fenoprofen—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	2.82e-05	0.000975	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—GSTT1—urinary bladder cancer	2.76e-05	0.000954	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.72e-05	0.000939	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—ENO2—urinary bladder cancer	2.7e-05	0.000932	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—RBX1—urinary bladder cancer	2.56e-05	0.000883	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.53e-05	0.000876	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—TYMP—urinary bladder cancer	2.53e-05	0.000873	CbGpPWpGaD
Fenoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.52e-05	0.00087	CbGpPWpGaD
Fenoprofen—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	2.46e-05	0.000851	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—RRM2—urinary bladder cancer	2.44e-05	0.000843	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.43e-05	0.000839	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—PLAU—urinary bladder cancer	2.32e-05	0.000803	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—NQO1—urinary bladder cancer	2.29e-05	0.000792	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—JAG1—urinary bladder cancer	2.29e-05	0.000791	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—NAT2—urinary bladder cancer	2.28e-05	0.00079	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—ENO2—urinary bladder cancer	2.26e-05	0.00078	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—HPGDS—urinary bladder cancer	2.26e-05	0.00078	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.24e-05	0.000776	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.22e-05	0.000769	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—GSTT1—urinary bladder cancer	2.19e-05	0.000757	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.16e-05	0.000745	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—RRM2—urinary bladder cancer	1.97e-05	0.000682	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.94e-05	0.000671	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—CREBBP—urinary bladder cancer	1.92e-05	0.000662	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—GSTP1—urinary bladder cancer	1.91e-05	0.000661	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—IGF1—urinary bladder cancer	1.89e-05	0.000654	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.85e-05	0.000639	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—HPGDS—urinary bladder cancer	1.83e-05	0.000631	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—ENO2—urinary bladder cancer	1.83e-05	0.000631	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—NQO1—urinary bladder cancer	1.82e-05	0.000629	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.82e-05	0.000628	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—TYMS—urinary bladder cancer	1.78e-05	0.000614	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—GSTT1—urinary bladder cancer	1.77e-05	0.000612	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—GSTM1—urinary bladder cancer	1.76e-05	0.000607	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—NCOR1—urinary bladder cancer	1.76e-05	0.000607	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.74e-05	0.000603	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—RHOA—urinary bladder cancer	1.73e-05	0.000599	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—GPX1—urinary bladder cancer	1.68e-05	0.000582	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—NCOR1—urinary bladder cancer	1.67e-05	0.000576	CbGpPWpGaD
Fenoprofen—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.66e-05	0.000573	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—ERCC2—urinary bladder cancer	1.65e-05	0.000571	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—ERCC2—urinary bladder cancer	1.57e-05	0.000541	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—MTHFR—urinary bladder cancer	1.55e-05	0.000537	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.54e-05	0.000532	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—GSTP1—urinary bladder cancer	1.52e-05	0.000525	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—NQO1—urinary bladder cancer	1.47e-05	0.000509	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—MTHFR—urinary bladder cancer	1.47e-05	0.000509	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.47e-05	0.000508	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—TERT—urinary bladder cancer	1.47e-05	0.000507	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—IL2—urinary bladder cancer	1.45e-05	0.000503	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.43e-05	0.000494	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.41e-05	0.000488	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.39e-05	0.000482	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.39e-05	0.000482	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—FGFR3—urinary bladder cancer	1.35e-05	0.000466	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.34e-05	0.000462	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.31e-05	0.000453	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—EP300—urinary bladder cancer	1.3e-05	0.000451	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—SRC—urinary bladder cancer	1.27e-05	0.000439	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.26e-05	0.000435	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.25e-05	0.000431	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.23e-05	0.000426	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—GSTP1—urinary bladder cancer	1.23e-05	0.000425	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.21e-05	0.000418	CbGpPWpGaD
Fenoprofen—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.19e-05	0.000411	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—CREBBP—urinary bladder cancer	1.15e-05	0.000396	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—TYMS—urinary bladder cancer	1.14e-05	0.000395	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—GSTM1—urinary bladder cancer	1.13e-05	0.00039	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—NCOR1—urinary bladder cancer	1.13e-05	0.00039	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—GPX1—urinary bladder cancer	1.08e-05	0.000374	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—ERCC2—urinary bladder cancer	1.06e-05	0.000367	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—KRAS—urinary bladder cancer	1.05e-05	0.000363	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—RHOA—urinary bladder cancer	1.04e-05	0.000359	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—PPARG—urinary bladder cancer	9.99e-06	0.000346	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—MTHFR—urinary bladder cancer	9.97e-06	0.000345	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—PTGS2—urinary bladder cancer	9.9e-06	0.000342	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—CREBBP—urinary bladder cancer	9.6e-06	0.000332	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—ERBB2—urinary bladder cancer	9.6e-06	0.000332	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—TP53—urinary bladder cancer	9.34e-06	0.000323	CbGpPWpGaD
Fenoprofen—ALB—Hemostasis—HRAS—urinary bladder cancer	8.93e-06	0.000309	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—PTEN—urinary bladder cancer	8.64e-06	0.000299	CbGpPWpGaD
Fenoprofen—PTGS1—Metabolism—EP300—urinary bladder cancer	8.24e-06	0.000285	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—CDKN1A—urinary bladder cancer	8.21e-06	0.000284	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—PTEN—urinary bladder cancer	8.19e-06	0.000283	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—PPARG—urinary bladder cancer	8.09e-06	0.00028	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—EP300—urinary bladder cancer	7.81e-06	0.00027	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—CREBBP—urinary bladder cancer	7.77e-06	0.000269	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—SRC—urinary bladder cancer	7.59e-06	0.000263	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—PTEN—urinary bladder cancer	6.86e-06	0.000237	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—MYC—urinary bladder cancer	6.8e-06	0.000235	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—EGFR—urinary bladder cancer	6.66e-06	0.00023	CbGpPWpGaD
Fenoprofen—PTGS2—Metabolism—EP300—urinary bladder cancer	6.54e-06	0.000226	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—PTGS2—urinary bladder cancer	6.36e-06	0.00022	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—KRAS—urinary bladder cancer	6.29e-06	0.000217	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—PTEN—urinary bladder cancer	5.55e-06	0.000192	CbGpPWpGaD
Fenoprofen—PTGS2—Disease—HRAS—urinary bladder cancer	5.34e-06	0.000185	CbGpPWpGaD
Fenoprofen—ALB—Metabolism—EP300—urinary bladder cancer	5.29e-06	0.000183	CbGpPWpGaD
